Max Financial to raise ₹2,000 crore via QIP. Manorama Industries to raise ₹500 crore via securities. Balaji Amines hit by ammonia supply issues. IOB revises MCLR rates. Here are few stocks to track ahead of Friday’s trading session.
2 Min Read
1 / 6Manorama Industries | The company’s board approved raising up to ₹500 crore through issuance of securities, including equity shares, non-convertible debt instruments, warrants or other convertible instruments. The fundraise may be executed via qualified institutional placements or other permitted routes, in one or more tranches, subject to regulatory and shareholder approvals, as part of the company’s capital raising plans going forward.
2 / 6Max Financial Services | The company’s board has approved raising up to ₹2,000 crore through a Qualified Institutional Placement (QIP) or other permissible methods. The fundraise may be executed in one or more tranches, subject to necessary approvals. The move is aimed at strengthening the company’s capital base and supporting future growth plans.
3 / 6Balaji Amines | The company is facing logistics disruptions in ammonia procurement due to the ongoing West Asia war, impacting the supply of a key raw material. As a result, some of the company’s plants have temporarily become non-operational owing to the ammonia shortage. The company is monitoring the situation closely and working to manage operations amid the supply disruption.
4 / 6JK Lakshmi Cement | The company has been declared the preferred bidder for the Juipahar New Umrangso Limestone Block (A and B) in an e-auction conducted by the Government of Assam. The mining lease covers an area of 405 hectares in Assam and was awarded following the company’s participation in the auction process.
5 / 6Indian Overseas Bank (IOB) | The bank’s board has announced its revised Marginal Cost of Funds Based Lending Rate (MCLR) effective from March 15, 2026. While the bank reduced its One-Month MCLR by 10 bps to 8.20%, it kept rates for all other tenors unchanged. Notably, the one-year MCLR remains steady at 8.80%, maintaining consistent borrowing costs for most term loans.
6 / 6Nectar Lifesciences Ltd | The company’s board has signed an inter-corporate loan agreement of up to ₹100 crore with its wholly owned subsidiary Avensis Exports Private Ltd. The unsecured facility, carrying 12% annual simple interest and a 10-year tenure, will support general corporate purposes. The related-party transaction was executed at arm’s length without special rights or security, the company said.
